Published in Annals of Internal Medicine · View the paper (DOI)
Researchers found that a combination of symptom and high-level viral rebound after untreated COVID-19 infection is rare, occurring in only 3 percent of study participants. This suggests that accounting for underlying rates of symptom relapse is crucial when evaluating antiviral treatment effects.
Coverage from 2 institutions
- Symptom and viral rebound uncommon after untreated COVID-19 infection American College of Physicians · Feb 20, 2023 · first to report
- Among untreated patients with COVID-19, combined symptom and viral rebound is rare Brigham and Women's Hospital · Apr 5, 2023